These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 6897258)

  • 21. Characterization of N-formyl-methionyl-leucyl-phenylalanine receptors on human neutrophils. Effects of isolation and temperature on receptor expression and functional activity.
    Tennenberg SD; Zemlan FP; Solomkin JS
    J Immunol; 1988 Dec; 141(11):3937-44. PubMed ID: 2846695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formyl peptide-induced chemotaxis of human polymorphonuclear leukocytes does not require either marked changes in cytosolic calcium or specific granule discharge. Role of formyl peptide receptor reexpression (or recycling).
    Perez HD; Elfman F; Marder S; Lobo E; Ives HE
    J Clin Invest; 1989 Jun; 83(6):1963-70. PubMed ID: 2723068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fc receptor-mediated desensitization of superoxide (O2-) generation response of guinea-pig macrophages and polymorphonuclear leucocytes.
    Yagawa K; Kaku M; Ichinose Y; Aida Y; Tomoda A
    Immunology; 1985 Aug; 55(4):629-38. PubMed ID: 2991127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oriented migration of rat polymorphonucleocytes induced by 4-hydroxynonenal and formylmethionyl-leucyl-phenylalanine].
    Curzio M; Torriello MV; Dianzani MU
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1672-8. PubMed ID: 6897768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.
    Anderson DC; Hughes BJ; Smith CW
    J Clin Invest; 1981 Oct; 68(4):863-74. PubMed ID: 7287906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of a specific receptor for formyl-methionyl-leucyl-phenylalanine on th pulmonary alveolar macrophage and its relationship to chemotaxis and superoxide production.
    Spilberg I; Mehta J; Daughaday C; Simchowitz L
    J Lab Clin Med; 1981 May; 97(5):602-9. PubMed ID: 6260878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative effect of a protein kinase C inhibitor (H-7) on human polymorphonuclear neutrophil locomotion.
    Gaudry M; Perianin A; Marquetty C; Hakim J
    Immunology; 1988 Apr; 63(4):715-9. PubMed ID: 2835313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone.
    Perianin A; Labro MT; Hakim J
    Biochem Pharmacol; 1982 Oct; 31(19):3071-6. PubMed ID: 6756410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor. Distinct from the pathway for superoxide anion production.
    Yasui K; Yamazaki M; Miyabayashi M; Tsuno T; Komiyama A
    J Immunol; 1994 Jun; 152(12):5922-9. PubMed ID: 8207217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.
    Rollins TE; Zanolari B; Springer MS; Guindon Y; Zamboni R; Lau CK; Rokach J
    Prostaglandins; 1983 Feb; 25(2):281-9. PubMed ID: 6304818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of human neutrophils and HL-60 cells with the extracellular matrix.
    Suchard SJ
    Blood Cells; 1993; 19(2):197-221, discussion 221-3. PubMed ID: 7508769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotaxis, spreanding nd oxidative metabolism of neutrophils: influence of albumin in vitro.
    Valerius NH
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):43-9. PubMed ID: 6306991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of filter-bound IgA in inhibiting polymorphonuclear leukocyte chemotaxis.
    Schröder JM; Christophers E
    Immunobiology; 1983 Mar; 164(2):127-35. PubMed ID: 6852861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in polymorphonuclear leukocyte aggregating responses among several species in response to chemotactic stimulation.
    Oseas RS; Boxer LA; Butterick C; Baehner RL
    J Lab Clin Med; 1980 Aug; 96(2):213-21. PubMed ID: 7400660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.
    Senior RM; Skogen WF; Griffin GL; Wilner GD
    J Clin Invest; 1986 Mar; 77(3):1014-9. PubMed ID: 3005361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsteroidal anti-inflammatory drug as tools for analysis of neutrophil functions.
    Périanin A; Giroud JP; Hakim J
    Biomed Pharmacother; 1987; 41(6):315-21. PubMed ID: 3446289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
    Dahinden C; Fehr J
    J Clin Invest; 1980 Nov; 66(5):884-91. PubMed ID: 7430350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.